GLP-1 receptor agonists are licensed for type 2 diabetes and weight management, not menopausal symptoms These medications work by enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite Weight loss from GLP-1 therapy may theoretically influence vasomotor symptoms, but robust clinical trial evidence is lacking Hormone replacement therapy remains the most effective first-line treatment for moderate to severe hot flashes in the UK Common GLP-1 side effects include gastrointestinal symptoms, with risks of pancreatitis and gallbladder disease requiring monitoring Table of Contents What Are GLP-1 Medications and How Do They Work
Separately it notes tirzepatide itself is contraindicated with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, and says that screening comes before any supplement discussion
The compounding pharmacy market has exploded with the demand for GLP-1 medications, and quality varies dramatically
While higher dosages produced greater weight loss, moderate doses already provided strong metabolic improvements with fewer side effects
Specifically, Keytruda is approved in combination with carboplatin and paclitaxel, followed by the anti-PD-1 therapy, as a single agent
Diarrhea occurs in roughly 30% of users, usually mild and temporary
